"Impact of Targeted Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)"

NARecruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Early Breast CancerNeoadjuvant Treatment

Interventions

DIETARY_SUPPLEMENT

omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (hexadecenoic acid)

Nutritional supplements

Trial Locations (1)

RECRUITING

AOU Maggiore della Carità, Novara

All Listed Sponsors

lead

University of Eastern Piedmont

OTHER